Difference between revisions of "Template:Team:TU Eindhoven/Stakeholders HTML"

Line 12: Line 12:
 
<br />
 
<br />
 
<h2>General</h2>
 
<h2>General</h2>
<h3>RIVM & Rathenau</h3><img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
+
<ul>
 +
 
 +
<li><h3>RIVM & Rathenau</h3><img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 
<div class="spoiler" id="spoiler2">
 
<div class="spoiler" id="spoiler2">
 
<div class="textImage">
 
<div class="textImage">
Line 30: Line 32:
 
</div>
 
</div>
 
</div>
 
</div>
 +
</li>
 +
 +
 
</html>
 
</html>

Revision as of 06:43, 15 September 2015





Stakeholders


To obtain more insight in the feasibility of our idea, we talked to many experts within different fields. Among the people we approached are doctors, researchers, students, but also people working in non-academic fields such as at ministeries and professional advisors. Each of them was invited to give their perspectives on our work. We also wondered if they could see the benefits of our device within our application scenarios and if they had any other suggestions for usage. Moreover, we gave them space to criticize our idea, and thereby advise us about aspects of our design that could be perfected. With their involvement, we could further develop our ideas. A short overview of each talk is given below.

General

  • RIVM & Rathenau

    COMBs are inherently modular and the use of aptamers allows for the detection of a virtually all disease markers. To give an overview of the possibilities our COMBs offer, we sketch three application scenarios. The first application scenario concerns the zoonosis Q Fever, of which a large outbreak was reported in the Netherlands in 2007. The second application concerns the use of COMBs within the gastrointestinal tract. The third application scenario is aimed at countering pesticide overuse. Read more on our application scenarios here: